Schedule 13G ownership disclosure

CYBIN INC

Common Stock, no par value · CUSIP: 23256X407

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 1,830,097.00 · Class: 9.1%

  • KEVIN TANG

    Shares: 1,830,097.00 · Class: 9.1%

  • TANG CAPITAL PARTNERS, LP

    Shares: 1,248,047.00 · Class: 6.2%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 582,050.00 · Class: 2.9%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-007871
Form type
SCHEDULE 13G/A
Filer
Helus Pharma Inc.
CIK
CIK 1833141
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub